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BACKGROUND: Modeling suggests that climate change mitigation actions can have substantial human health benefits that accrue quickly and locally.
Documenting the benefits can help drive more ambitious and health-protective climate change mitigation actions; however, documenting the adverse
health effects can help to avoid them. Estimating the health effects of mitigation (HEM) actions can help policy makers prioritize investments based
not only on mitigation potential but also on expected health benefits. To date, however, the wide range of incompatible approaches taken to develop-
ing and reporting HEM estimates has limited their comparability and usefulness to policymakers.
OBJECTIVE: The objective of this effort was to generate guidance for modeling studies on scoping, estimating, and reporting population health effects
from climate change mitigation actions.
METHODS: An expert panel of HEM researchers was recruited to participate in developing guidance for conducting HEM studies. The primary litera-
ture and a synthesis of HEM studies were provided to the panel. Panel members then participated in a modified Delphi exercise to identify areas of
consensus regarding HEM estimation. Finally, the panel met to review and discuss consensus findings, resolve remaining differences, and generate
guidance regarding conducting HEM studies.
RESULTS: The panel generated a checklist of recommendations regarding stakeholder engagement: HEM modeling, including model structure, scope
and scale, demographics, time horizons, counterfactuals, health response functions, and metrics; parameterization and reporting; approaches to uncer-
tainty and sensitivity analysis; accounting for policy uptake; and discounting.
DISCUSSION: This checklist provides guidance for conducting and reporting HEM estimates to make them more comparable and useful for policy-
makers. Harmonization of HEM estimates has the potential to lead to advances in and improved synthesis of policy-relevant research that can inform
evidence-based decision making and practice. https://doi.org/10.1289/EHP6745
Introduction
In 2015, 196 countries outlined their Nationally Determined
Contributions (NDCs) as part of the 2015 Paris Agreement of the
United Nations Framework Convention on Climate Change
(UNFCCC), with the goal of avoiding dangerous climate change
of 2°C over preindustrial levels (The Paris Agreement). The sci-
entific community has since reiterated that holding warming
below 1.5°C could avoid key environmental tipping points and
prevent substantial climate-related risks to natural and human
systems (Rogelj et al. 2018; UNFCCC 1992). Current climate
change mitigation efforts, however, fall far short. Greenhouse gas
emissions (GHGE) reached a record high in 2018 globally, which
also saw continuing expansion of fossil fuel use and reduced rates
of renewable energy installation (IEA 2019). Further, the opera-
tional guidelines outlined in the Katowice Package (UNFCCC
n.d.b) set out the undertaking of a Global Stocktake that will
make use of the “best-available science” for mitigation (and
other Paris Agreement thematic areas) (UNFCCC n.d.a). For
studies of the health effects of mitigation (HEM) to make a
meaningful contribution to this global effort, common standards
are needed to facilitate synthesis through meta-analysis and
other approaches (Chang et al. 2017).
Although climate change mitigation is an urgent priority,
policy implementation has been limited, often due to associated
short-term financial costs (Workman et al. 2018). However, cost
assessments rarely account for concomitant impacts (generally
subdivided into co-benefits and co-harms), i.e., “the . . . effects that
a policy or measure aimed at one objective might have on other
objectives” (Allwood et al. 2014). Comprehensive accounting of
co-benefits and adverse side effects is essential (Zenghelis 2006)
because beneficial mitigation externalities may enhance the eco-
nomic case for pursuing aggressive mitigation action (Rogelj et al.
2018). (Haines et al. 2009). Systematic reviews of HEM studies
estimating actions, policies, interventions, and technologies have
found that mitigation can lead to near-term changes in local and re-
gional air quality, transportation behaviors, and dietary intake that
have significant health benefits, with broader benefits accruing in
the longer term (Chang et al. 2017; Gao et al. 2018) (See Figure 1;
note this is not intended to be comprehensive). In most cases these
health effects are beneficial, and their economic valuation could
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offset a substantial proportion of mitigation costs, particularly in
emerging economies (Smith andHaigler 2008).
Despite this, HEM research appears to have had limited pol-
icy impact. Evidence of mitigation co-benefits outside of health,
e.g., for development (economic and scientific advancement) and
for benevolence (a more moral and caring community) has moti-
vated support for mitigation actions (Bain et al. 2016). But HEM
research has gained minimal political traction and to date has
done little to influence climate change policy (Workman et al.
2018). Influencing policy making with research evidence is a
complex process (Cairney and Oliver 2017; Oliver and Cairney
2019). Experience with other population health challenges such
as air quality and tobacco abuse suggests that important elements
include developing a consistent and compelling body of evi-
dence, linking research with a coalition or network approach to
advocacy, being prepared to take advantage of windows of op-
portunity, and developing an understanding of how the ideologi-
cal beliefs of decision makers influence the framing of policy
proposals (Rose et al. 2017; Smith 2013).
Increasing the policy influence of HEM research necessitates
reducing potential barriers and promoting potential facilitators of
its uptake. Two previously identified barriers are resistance from
powerful vested interests and structural challenges that limit cross-
sectoral collaboration between the health sector and climate
change decision makers (Workman et al. 2018). Another barrier is
the lack of a compelling, harmonized evidence base because cur-
rent evidence consists primarily of heterogeneouslymodeled HEM
estimates. Although there is broad agreement about the general
approach to modeling HEM (Remais et al. 2014; Smith and
Haigler 2008), the broad array of mitigation actions and wide vari-
ety of specific modeling approaches taken have precluded meta-
analysis (Chang et al. 2017; Gao et al. 2018). There is currently no
clear framework for advancing HEM research methods and results
reporting, and compelling examples of how concomitant impacts
on health (beneficial and adverse) have accrued from mitigation
activities are still needed. In sum, basic guidance that would
enhance the policy utility of HEM estimates are lacking, including
for scoping, estimating, and reporting research onHEM.
With these concerns in mind, the Wellcome Trust, the World
Health Organization (WHO), and the University of Washington
coconvened a workshop to identify strategies for enhancing the
policy utility of HEM estimates, with a focus on developing guid-
ance that could help improve the applicability and comparability
of HEM evidence. Shortcomings in current research and report-
ing practices were identified, and a consensus process was under-
taken to arrive at a minimal set of reporting guidelines to
promote transparency, interpretability, and uptake of HEM esti-
mation. Herein we present the methods used to generate consen-
sus regarding these issues as well as the resulting practice and
reporting guidance that emerged.
Methods
Several methods across multiple stages were used to develop this
guidance, including a review and synthesis of the literature, as-
sembly of an expert panel, a modified Delphi consensus-building
process, an expert workshop to develop preliminary guidance,
and postworkshop guidance refinement (Figure 2).
Literature Review
A literature review was conducted to provide material for the
expert panel and the modified Delphi process. The review covered
Figure 1. A conceptual framework that provides sector-specific examples of the multiple mechanisms and pathways through which climate change mitigation
policies can affect human health. This figure is not intended to be comprehensive.
Figure 2. Timeline and process for developing guidance document. R1, R2, and R3 were successive rounds.
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HEM studies published between 1 February 2017 and 1 February
2019, building on prior reviews of studies conducted before that
period (Chang et al. 2017; Gao et al. 2018). Papers were classified
according to mitigation scenario and sector, geographic scale,
health metrics used, health outcomes estimated per CO2 equivalent
averted, monetized benefits, and treatment of uncertainty. The
papers identified were provided to the expert panel, along with a
narrative synthesis of the review findings.
Expert Panel Assembly
An expert panel was assembled based on researchers identified in
the literature review. Experts were contacted via electronic mail
and asked to participate in the panel. First contact was made with
first and senior authors; substitutions were allowed upon mutual
agreement between the organizing team and the initially con-
tacted expert. Panelists were asked to participate only if they
could engage through the entire process. Sixty-four panelists
were recruited. All panel members were invited to the workshop
and to participate in editing the guidance document. All partici-
pating panelists are included as authors.
Modified Delphi Process
The Delphi process is a general method designed to measure and
reach consensus. Our modified Delphi consisted of three rounds
of anonymous, online surveys with two categories of predefined
questions, similar to those of other Delphi processes (Boulkedid
et al. 2011). The first category consisted of affirmatively phrased
declarative statements related to HEM estimation practices and to
the potential utility of guidance from the EQUATOR Network
(an international initiative to promote reporting guidelines for
published health research) (EQUATOR Network n.d.) and else-
where on modeling studies (Bennett and Manuel 2012; Stevens
et al. 2016), observational studies (von Elm et al. 2007), and
health impact assessments (HIAs) (Bhatia et al. 2014). Panelists
were asked to express the degree of agreement on a scale of 1
to 9, with 1 indicating strong disagreement and 9 indicating
strong agreement, and to provide a narrative justification for their
responses. The second category of questions was exploratory and
meant to prioritize topics for further discussion and to generate
additional areas in which to seek consensus. Between survey
rounds, panelists were given descriptive analyses of responses
and summaries of narrative comments from the prior round. Each
survey is included in the Supplementary Materials. Panelists also
had full, anonymized access to all raw data and responses.
Consensus was determined by measures of central tendency and
spread in the third round of questioning, with a mean score and
interquartile range (IQR) between 1 and 3 indicating consensus
against and a mean and IQR between 6 and 9 indicating consen-
sus for a given statement.
Guidance Refinement
Panelists convened in London in March 2019 in a workshop spon-
sored by the Wellcome Trust and coconvened with WHO and the
University of Washington. The overarching goal was to reach con-
sensus on key issues surrounding health co-benefits research.
Building from and guided by the modified Delphi process, the 3D
workshop used small group discussions combined with report-
back presentations to discuss key elements of the survey and, when
possible, reach consensus. In total, 53 researchers encompassing a
range of expertise on climate change mitigation health co-benefits
research attended the workshop (Table S1). Small group discus-
sions were moderated by preselected facilitators, and discussion
notes were taken and summarized by rapporteurs.
Small group discussions were held on the following issues:
stakeholder engagement, modeling approaches, model parameter-
ization and treatment of uncertainty, and reporting. Due to the
current state of the literature, which disproportionately focuses
on air pollution and active transport, workshop discussions were
largely focused on these areas, with a secondary focus on food
systems, the built environment, and urban form. The workshop
concluded with a plenary discussion of consensus guidance state-
ments, including the type of studies for which the guidance
should be designed. The guidance statements were assembled
into a draft document after the workshop and circulated to the
group, including those panelists who were unable to attend the
workshop, for review and refinement prior to publication.
Discussion
Here we present the consensus findings of the author panel
reflecting the outputs from the expert consensus process outlined
above. We first present “Practice and Reporting Guidance” and
then conclude with a “Discussion” section reflecting the perspec-
tive of the panel regarding the context for this guidance and its
implications for HEM estimation and reporting.
Practice and Reporting Guidance
The material in this section is the consensus recommendation of
the panel, unless noted in the text or otherwise attributed with a
citation. This statement begins with a brief discussion of guid-
ance scope and application. Next, there are three sections of rec-
ommended guidance: “Stakeholder Engagement,” “Modeling
Approaches,” and “Parameterization and Reporting.” A sche-
matic of the overall process to which the guidance applies is pre-
sented in Figure 3.
Scope and Application
Given the wide range of HEM research, it is important to delin-
eate the activity for which this guidance is designed and how the
guidance is intended to be implemented.
As noted earlier in the “Introduction,” prior research on
HEM determined that mitigation actions may result in substan-
tial health co-benefits, but the policy potential of this research
has not been fully achieved, partially as a result of wide vari-
ability in methods and reporting as well as the nonsystematic
nature of previous approaches (Remais et al. 2014; Gao et al.
2018). This guidance is meant to encourage specific modeling
practices, methods, and results reporting to maximize the likeli-
hood of implementing the most beneficial mitigation actions
and maximize the likelihood of avoiding adverse side effects.
As such, this guidance is particularly relevant to HEM research
focused on quantitative estimation of mitigation health co-
benefits via modeling of population health impacts associated
with specific mitigation actions. It is likely of less relevance
where the primary aim of a policy is not climate change mitiga-
tion, but both health and carbon impacts are modeled.
Practically, these guidelines are likely to be most relevant to
modeling efforts scoped for national and international efforts,
but they could also be applied subnationally in large countries
such as the United States, China, and India. It may be more
challenging to implement the guidance at local levels due to
resource constraints or lack of relevant downscaled modeling
inputs.
The guidance is meant to be comprehensive and provide a
checklist of standard practices and analysis reporting that can be
used by funders, researchers, reviewers, and journal editors in
scoping, preparing for, conducting, reporting, and reviewing
HEM research. Guidance recommendations are listed below,
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preceded by accompanying (and less prescriptive) background
text. Although we encourage following the guidance to maximize
comparability across studies and policy impact, we are not advo-
cating that adherence be required as a test of study quality or
asserting that studies that do not adhere to the guidelines neces-
sarily lack quality or rigor. Further, we acknowledge the need for
flexibility in modeling approaches, to avoid stifling both innova-
tion and research output from resource-poor settings where full
adherence to this checklist may not be feasible. Finally, we
acknowledge the importance of good modeling practice, includ-
ing the need to maintain a humble approach to modeling complex
systems, to frequently revisit modeling assumptions, and to con-
sistently seek to incorporate new evidence.
Stakeholder Engagement
As noted in the HIA literature (Bhatia et al. 2014) and other perti-
nent work on environmental health policy noted above (Rose et al.
2017; Smith 2013), a fundamental prerequisite of policy rele-
vance is stakeholder engagement, particularly with policymakers,
during research planning to improve usefulness of model inputs,
improve relevance of study design to policy context, and encour-
age policy uptake. The panel strongly encourages use of transdis-
ciplinary and interdisciplinary stakeholder teams (including
nonhealth disciplines) to reflect the broad range of methodologi-
cal, sociological, and other considerations. Modeling efforts
should consider including government policy makers, the public
and civil society, the private sector, and scientists from a variety
of relevant disciplines (e.g., health, mathematics, statistics, ecol-
ogy, economics, and other social sciences), as needed. Such
efforts could help lessen barriers to policy uptake and allow
researchers, decision makers, and funders to anticipate policy re-
sistance; encourage policy uptake; and account for variable
uptake of policy scenarios in analysis. Stakeholder engagement
may take multiple forms (Bhatia et al. 2014), employ a range of
tools (e.g., mapping, review of specific cases), and occur over a
variety of administrative and geographic scales. Expertise may
need to be added to the research team on effective approaches to
facilitating stakeholder engagement.
With these considerations in mind, the panel recommends the
following Engagement Guidelines:
1. Specify the primary decision maker(s) and/or target audi-
ence(s).
2. List and describe strategies used to facilitate stakeholder
engagement and communication with the target audience
throughout the HEM development and dissemination
process.
3. As relevant, describe involvement with knowledge brokers,
research uptake officers, policy advisors, and other stake-
holders at multiple stages of planning and implementation
(e.g., their role in selecting model inputs such as health
metrics).
4. As relevant, describe collaboration(s) with stakeholders
(whether at the affected community level, in academia, or
in government) in health-determining sectors (e.g., finance,
energy, transportation, housing, industry, food systems,
and agriculture).
5. As relevant, describe engagement between mitigation and
adaptation experts relevant to various phases of effort, from
planning to implementation and dissemination, including
any efforts to avoid unintended consequences.
Modeling approaches. There is clear value in different mod-
eling approaches, and our guidance does not prescribe specific
modeling approaches as long as the approach allows for incorpo-
ration of baseline population health information, demographics,
and evaluation of counterfactuals (i.e., what could happen with-
out the mitigation scenario). HEM models generally take the
Figure 3. Engagement, modeling, parameterization, reporting, and synthesis considerations for health effects of mitigation policies (HEM) studies, building on
figures originally published by Remais et al. (2014) and Gao et al. (2018).
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approach shown in Figure 3 and draw from a variety of methods,
including comparative risk assessment, complex mechanistic
modeling, and microeconomic and behavioral modeling, though
other approaches are sometimes employed (Remais et al. 2014).
Comparative risk assessment approaches allow for standardiza-
tion and comparison of risk, whereas mechanistic and behavioral
modeling can provide insights into systems dynamics and ques-
tions of how individuals, households, and other economic units
may respond to various policy options.
The panel recommends that modeling choices should be made
based on assessments of which approach is most appropriate for
the research question of interest and stakeholder input, as relevant.
We also recommend that counterfactual scenarios, exposure–
response functions (ERFs), health metrics, and study time frames
should be selected based on stakeholder input, the research ques-
tion posed, and health focus. In addition, we encourage modelers
to be explicit regarding the rationale for these selections. For
instance, although disability-adjusted life-years (DALYs) may be
appropriate for some international studies, quality-adjusted life-
years (QALYs), mortality rates, and loss of life expectancy (LLE)
may, depending on the context and stakeholder needs, be more ap-
plicable at national and subnational scales. Additionally, the con-
version of health metrics into monetary measures is a valuable
approach if conducted transparently because it may be particularly
compelling for policymakers and allows for the comparison of
impacts across several dimensions (e.g., financial costs vs. health
benefits).
For global and regional assessments, the panel recommends
that ERFs should generally be selected from systematic reviews
and meta analyses. However, when local evidence is of primary
importance to stakeholders or when there is reason to believe that
evidence generated elsewhere may not be generalizable to the
study setting (e.g., applying ERFs from high-income countries to
low-income countries or applying in a different climate region),
ERFs may be based primarily on local evidence. The STROBE
reporting guidelines for observational studies (von Elm et al.
2007) and PRISMA statement for systematic reviews (Moher
et al. 2009) can be useful in selecting which studies to incorpo-
rate. Time horizons should be similarly justified and selected
based on context. For example, time horizons for national studies
could be made congruent with national governmental policy
cycles, whereas time horizons for regional studies could align
with the sustainable development goals (United Nations n.d.). In
any case, researchers should clearly describe and justify the
parameterization choice.
We encourage, where possible and relevant, the use of ensem-
ble climate model projections that follow the Representative
Concentration Pathways (RCPs), the Shared Socioeconomic
Pathways (SSPs), or other globally agreed-upon scenarios. We
also encourage characterization of the uncertainties inherent in
scenario choice, temperature projections, model structure, and in-
ternal variability (Deser et al. 2012; Hawkins and Sutton 2009).
The RCPs include four emissions pathways developed primarily
by the integrated assessment modeling (IAM) community (van
Vuuren et al. 2011). The SSPs are a set of five reference scenar-
ios that capture plausible trends in “the evolution of society and
natural systems over the 21st century” by incorporating a range
of socioeconomic and environmental conditions (O’Neill et al.
2014). Taken together, the SSPs and RCPs can be used to explore
uncertainty in outcomes and projections, with one axis represent-
ing plausible socioeconomic and environmental conditions and
the other representing emissions pathways (O’Neill et al. 2014).
The use of the RCPs and SSPs would align the efforts of HEM
researchers with those of the larger climate modeling community,
although some HEM studies will be scoped and scaled such that
these scenarios will not be particularly relevant. For instance, in a
study aimed at evaluating the health impacts of changes in trans-
portation policy at a city scale or over a relatively short (i.e., dec-
adal) time span, neither the RCPs nor the SSPs are likely to add
perspectives that will be useful to stakeholders. The SSPs can
also be used, where relevant, to incorporate other drivers of
health outcomes, such as urbanization and inequity.
With these considerations in mind, the panel recommends the
following Modeling Approach Guidelines:
Mitigation Policies
1. Describe mitigation policies and scenarios and their rele-
vant sectors (e.g., finance, energy, transportation, housing,
industry, food systems including agriculture).
Geographic Area and Scale
2. Specify the geographic scale (international, regional,
national, subnational, city) and geographic area of interest.
Population and Demographic Considerations
3. Describe populations (size and other characteristics) for
model baseline and counterfactual scenarios.
4. If applicable, account for equity and describe socially and
economically marginalized populations.
5. If applicable, account for and describe populations that are
most likely to experience adverse consequences or benefit
the most.
6. List and describe data sources used for population and de-
mographic projections.
7. Describe the degree of congruence between population and
demographic data and emissions projections in terms of
time frame, underlying assumptions, and other factors
deemed relevant.
8. Describe why target population and demographic choices
for the baseline and counterfactuals are appropriate to the
policy decision(s) being considered.
9. Describe how the analyses will account for projected de-
mographic changes.
10. Describe whether and how the analyses will account for
feedbacks between and within models and across drivers
of population/demographic projections. If feedbacks are
not addressed, state why.
Counterfactual Scenarios
11. Describe how exposure(s) to the mitigation action(s) and
related downstream exposure(s) is assigned, including, as
appropriate, the proportion of the population that is
exposed over time as a function of implementation.
12. List and describe counterfactual scenarios, ensuring that
these reflect current realities in the absence of strong miti-
gation policies. As appropriate, list and describe other miti-
gation policies used in the model.
13. Describe any potential correspondence between mitigation
and counterfactual scenarios with SSPs, RCPs, and/or
other globally agreed-upon scenarios, either qualitatively
through narrative linkages (e.g., if the mitigation and coun-
terfactual scenarios are characteristic of particular scenar-
ios) or quantitatively (e.g., using specific combinations of
RCPs and SSPs with numerical correlates for emissions,
demographic shifts, etc.).
14. Describe data sources used for counterfactual scenarios
(for example, emission scenarios).
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Time Frames and Horizons
15. Specify and justify the baseline year for data sources used
in the model.
16. Clearly define and justify time frames and projected time
horizons.
Exposure–Response Functions
17. Describe and justify exposure–response functions used.
18. If applicable, describe how exposure–response functions
may vary among vulnerable and disadvantaged populations.
19. Describe health response studies used for modeling (e.g.,
description of sample size, location, timeframe) and justify
if health responses were not obtained from systematic
reviews or meta-analyses (e.g., use of local studies).
Health Metrics
20. Define and justify metric(s) for measuring the health of
populations (e.g., health metrics such as DALYs, years of
life lost (YLL), years lived with disability (YLD), mortal-
ity, LLE, hospitalizations, emergency department visits,
among others) appropriate for the specified causal path-
ways and target audience/decision makers.
21. Describe and justify data sources used for health metrics
(examples as above).
Baseline Health Estimates
22. Describe baseline population health estimates.
23. Describe and justify sources used for baseline health esti-
mates and demographics (e.g., national vital statistics, the
Global Burden of Disease study, etc.).
Parameterization and Reporting
We recommend quantitative analysis of uncertainty despite the
complications involved in doing so. In instances where sources of
uncertainty cannot be quantified, we recommend additional quali-
tative discussions. HEM researchers should also conduct sensitiv-
ity analyses to quantify (if possible, using value of information or
other methods) how input uncertainties, model parameters, and
model structure drive variability in model outputs. Both sensitivity
and uncertainty analyses should be conducted for the following:
exposure, economic valuation of health effects, the role of adapta-
tion in exposure–outcome associations, the magnitude and func-
tional form of exposure–outcome associations, and other inputs
such as demography and policy uptake. Researchers are also
encouraged to consider discounting intervention costs and impacts
if appropriate to the decision and decision-making context.
We encourage working with IAM and other modeling com-
munities to develop realistic rates of implementation for key poli-
cies. IAM is a commonly used approach in the climate science
community to integrate aspects of human systems (demography,
energy use, and the economy, among other features) with aspects
of the climate system (Moss et al. 2010). It has allowed for the
development of emissions scenarios such as the RCPs (van
Vuuren et al. 2011) and can be used to simulate feedback loops,
evaluate uncertainties, and provide insight into the benefits of cli-
mate change mitigation (Moss et al. 2010).
With these considerations in mind, the panel recommends the
following Parameterization and Reporting Guidelines:
Health Outcome Reporting
1. Report elements of component health metrics used (e.g.,
number of deaths or disease cases, baseline rates, percent attribut-
able, health events per capita, change in life expectancy).
2. Describe extent to which environmental exposures (e.g., air
pollutants), vs. demographic change, resulted in health impacts.
3. Conduct a sensitivity analysis and describe methods used.
4. Describe general study limitations qualitatively (e.g.,
describe potential sources of bias and likely impact on findings)
and quantitatively (e.g., describe limitations in valid parameter-
ization of model).
5. Where feasible, conduct quantitative uncertainty analysis,
particularly value of information methods to prioritize data and
research needs.
6. Discuss sources of uncertainty that could not be addressed
quantitatively.
7. Discuss potential and/or actual (social, political) resistance
to policy uptake either qualitatively or quantitatively (e.g.,
through incorporation of a step function for policy implementa-
tion over time).
8. Discuss adverse consequences of mitigation actions (poten-
tial, hypothetical, or those observed in results) either qualitatively
or quantitatively.
Accounting for Variable Policy Uptake
9. Differentiate scenarios between thought experiments (“first
best world”), maximum credible rates of implementation (“sec-
ond best world”), and realistic rates of implementation.
10. Describe equity impacts of policy uptake.
11. If possible, qualitatively discuss nonlinear dynamics
(e.g., delays and thresholds) associated with intervention imple-
mentation and expected outcomes using empirical data.
Discounting
12. For discounted valuation estimates, justify choice of fixed
vs. variable (e.g., certainty-equivalent) rates, specific rates cho-
sen, and conduct sensitivity analyses, including at least rates of
0% (with a 100-y time horizon) and 3%.
Data and Code Transparency
13. When legally and ethically possible, openly and publicly
share data and code used for HEM studies to facilitate model val-
idation of models by external researchers, collaboration between
investigators, and the production of meta-analyses (including
through retrospective harmonization), and new studies. If there
are legal or ethical limitations to data sharing, these should be ex-
plicitly stated.
Discussion
The guidance, which addresses stakeholder engagement, model-
ing approaches, parameterization, and reporting, is aimed at
quantitative modeling scoped to provide policy-relevant insights
that facilitate the selection and implementation of mitigation poli-
cies based both on mitigation potential and on anticipated health
impacts. This guidance may be most relevant to efforts at the
national or international level, although the guidance is also
likely relevant for subnational efforts in large countries and for
settings such as megacities. The ultimate aim of the guidance is
to generate estimates that are responsive to stakeholder needs and
that can be compared and combined to support policy decisions.
This guidance includes several departures from previous
work. First among them is the emphasis on stakeholder engage-
ment, which is a fixture of other policy-oriented activities such as
HIA (Lock 2000). This guidance reflects and underscores the pri-
ority of policy relevance in HEM research. Although we stop
short of stipulating that stakeholders always be engaged in HEM
efforts as stipulated in HIA guidance (Bhatia et al. 2014),
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consensus nonetheless emerged among the panel members that
stakeholder engagement, including engagement of potentially
affected civil society and community members and sectors out-
side health, would likely enhance evidence uptake into policy.
Resources from the HIA practice community (SOPHIA
Stakeholder Engagement Working Group 2015; SOPHIA n.d.)
may be relevant for stakeholder engagement in future HEM
efforts.
Another departure is the emphasis on using common scenar-
ios in modeling efforts. Socioeconomic and development trends
will affect baseline mortality rates over the coming decades, and
adopting the SSPs as a standard set of reference pathways can
enhance comparability across studies. Relevant quantifications of
the SSPs are available (Dellink et al. 2015; Jiang and O’Neill
2017; Kc and Lutz 2017; Li et al. 2019; Marangoni et al. 2017;
Nepal et al. 2019; Rao et al. 2019), and there is increasing appli-
cation in the health sector (Markandya et al. 2018; Sellers and
Ebi 2017). Using the SSPs, Sellers projects different burdens of
noncommunicable disease (NCD) mortality as a proportion of all
deaths, particularly in low- and middle-income countries
(LMICs), depending on development pathways (Sellers 2020), a
relevant trend for future baseline population health estimates in
HEM studies.
A third departure is the encouragement to incorporate demo-
graphic projections and more realistic assumptions regarding pol-
icy implementation. Many HEM studies made the simplifying
and unrealistic assumption that the mitigation action of interest is
imposed on today’s world immediately and uniformly worldwide,
with a constant population, despite the presence of a wide range
of possible population distributions over coming decades, both in
terms of numbers of people (6.9–12.6 billion in the year 2100,
depending on socioeconomic development pathway) and in terms
of the age structures and health status of populations (Kc and
Lutz 2017).
Less of a departure, but still an important practice innovation,
is the emphasis on a) standardized metrics of health impacts, b)
more comprehensive causal pathways linking exposures and
health impacts, and c) incorporation of climate change into pro-
jected changes in exposure. Air pollution provides an example of
the importance of these issues. As understanding of the wide
range of health impacts of exposure to fine particulate matter
(PM2:5) continues to increase, it has become clear that some
recent HEM studies underestimated the ancillary health benefits
of reducing PM2:5 exposure. A 2019 review by five national aca-
demies of science and medicine concluded that associations were
unequivocal between PM2:5 and heart disease, stroke, chronic ob-
structive lung disease, lung cancer, premature birth, dementia,
and brain development (Academy of Science of South Africa,
Brazilian Academy of Sciences, German National Academy of
Sciences Leopoldina, U.S. National Academy of Medicine, U.S.
National Academy of Sciences 2019), with additional adverse
health outcomes reported in individual epidemiology studies. A
2017 review of projections of health risks from ozone and partic-
ulate matter under different climate change scenarios concluded
that climate change is expected to worsen air quality by changing
atmospheric processes and chemistry, resulting in increases in
mortality, with results differing by region, scenario, and other
factors (Orru et al. 2017). Since the preindustrial period, climate
change already increased the global population-weighted fine
particle (PM2:5) concentrations by 5% and the near-surface ozone
concentrations by 2% (Fang et al. 2013). Projections should
take into account the complex interactions between climate
change and air pollution, such as climate change constraining
improvements in air quality in some regions (Trail et al. 2014).
Incorporating the interactions among air pollution, climate
change, health, and demography into HEM analyses and express-
ing these impacts using standardized metrics inclusive of morbid-
ity and mortality would increase the accuracy and comparability
of the estimates.
If implemented widely, we expect that the recommended guid-
ance would lead to increased methodological harmonization in
HEM studies and thereby enhance comparability and synthesis. As
several reviews of mitigation health co-benefits literature high-
lighted (Chang et al. 2017; Gao et al. 2018; Haines et al. 2009;
Remais et al. 2014; Smith and Haigler 2008), the variety of meth-
ods used to quantify mitigation health co-benefits has limited the
extent to which results can be synthesized, particularly through
meta-analysis. These reviews codified the HEM process but
stopped short of providing prescriptive guidance. Implementation
of this guidance should facilitate combining future HEM research
estimates using meta-analyses and other approaches such as multi-
criteria decision analysis (Huang et al. 2011; Linkov et al. 2006;
Wilson 2015; Yokota and Thompson 2004; Zhang et al. 2016). We
recognize that the selection of modeling techniques will be
context-specific, at the discretion of study groups, and scaled to a
level that is relevant to decision makers. However, harmonization
of modeling methods where appropriate and explicitly reporting
the rationale for modeling approaches will facilitate synthesis,
modeling at global scales, and greater policy impact, and allow for
integration with other evidence from controlled and observational
studies. As a corollary, the emphasis on open source data and code
sharing for modeling, echoing other relevant EQUATOR Network
guidance, will also facilitate comparison, retrospective harmoniza-
tion, and understanding of the implications of methodological
choices and untangling of differences due to use of different data
sources, assumptions, and scenarios.
The panel notes that this guidance will likely require additional
resources to implement and build global capacity to support stake-
holder engagement, incorporation of additional team members,
broader uncertainty analyses, and transparency regarding source
data and model code. Identifying the needed resources may be a
challenge because HEM research is already inadequately funded
(Ebi et al. 2009) and more limited in scope than models of the eco-
nomic costs and benefits of climate change mitigation. An implica-
tion of the guidance related to engagement is that additional
investments are needed specifically to support transdisciplinary and
interdisciplinary teams (e.g., funding for economists on teams of
health researchers; improved stakeholder/decision maker engage-
ment; strengthening partnerships and capacity of LMICs; increasing
access to data sources, particularly in LMICs; and research on
highly exposed and/or highly susceptible populations with lower
adaptive capacity). Although some federal funding supports such
efforts, such as the National Science Foundation’s Convergence
Research efforts, further investments are needed to update models
as new insights are gained, for instance, into causal pathways.
Investments by national funding agencies, foundations, and nongo-
vernmental organizations would lead to better-informed mitigation
decisions, building amore resilient and sustainable future.
A final point bears mention. This guidance is particularly rele-
vant to large-scale HEM modeling efforts aimed at prioritizing
mitigation investments and highlights the importance of consider-
ing implementation in modeling mitigation actions. Our expert
panel was unanimous in highlighting the need for concomitant,
parallel discussion of implementation, to include developing
implementation case studies and other approaches to building the
evidence base related to recognition, documentation, maximiza-
tion, and publicization of mitigation health co-benefits—both to
inform HEM modeling efforts and to facilitate rapid, effective
implementation, of the policies that have been assessed to effec-
tively promote optimal population health.
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The guidance provided here can, with modification, be
applied to other questions, such as the health effects of strategies
to reduce urban heat islands through greening programs. As noted
above, the potential relevance of such interventions for local pop-
ulation health and policy may justify their study despite a likely
smaller global mitigation impact.
The need for better understanding, estimation, and reporting of
the health effects of mitigation is clear. These guidelines have been
developed to help improve the quality of modeling studies to
informmitigation policies. Improving this evidence base is critical
to ensuring health is fully considered in mitigation strategies,
encouraging both more mitigation and better design of mitigation
to minimize negative health effects and maximize positive health
effects. It is our hope that harmonization of health co-benefits stud-
ies will help inform better policy and thus improve public health
outcomes.
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